Management of Heart Failure in Advancing CKD: Core Curriculum 2018

Area of Science:

• Cardiology
• Nephrology
• Internal Medicine

Background:

• Heart failure (HF) and chronic kidney disease (CKD) are increasingly prevalent, particularly in aging populations.
• Hypertension, diabetes, and cardiovascular disease risk factors contribute to the rising incidence of HF and CKD.
• The co-occurrence of HF and CKD exacerbates risks for hospitalization, morbidity, mortality, and healthcare costs.

Observation:

• Patients with advanced CKD (stage 4) are often excluded from pivotal HF clinical trials.
• This exclusion creates a knowledge gap in managing HF with reduced ejection fraction (HFrEF) in patients with significant kidney impairment.
• A case study of HFrEF in stage 4 CKD illustrates management complexities.

Findings:

• Current HF management guidelines may not be fully applicable to patients with advanced CKD.
• Treatment decisions require careful consideration of renal function and potential drug toxicities.
• Evidence-based strategies for this specific patient population are limited.

Implications:

• There is a critical need for clinical trials including patients with advanced CKD to inform HFrEF management.
• Developing tailored treatment protocols for comorbid HF and CKD is essential.
• Improved understanding and management strategies can reduce adverse outcomes and healthcare burden.